Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection
Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Open labelled, non randomized study to evaluate the effects of Artemisinin based Combined
Therapies(ACTs) on schistosomiasis since Praziquantel (PZQ) which is presently the drug of
choice for treating Schistosomiasis (STS), is ineffective on immature stages and there is
known parasite resistance. ACTs when combined with PZQ, targeting different stages of the
life cycle has shown some effectivity.